Fiorella Ruatta

408 total citations
26 papers, 200 citations indexed

About

Fiorella Ruatta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fiorella Ruatta has authored 26 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Fiorella Ruatta's work include Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (4 papers) and Renal cell carcinoma treatment (3 papers). Fiorella Ruatta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (4 papers) and Renal cell carcinoma treatment (3 papers). Fiorella Ruatta collaborates with scholars based in Italy, France and Sweden. Fiorella Ruatta's co-authors include Yohann Loriot, Lisa Derosa, Bernard Escudier, G. Baciarello, Ornella Garrone, Karim Fizazi, Annalisa Guida, Émeline Colomba, Laurence Albigès and Marco Merlano and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Fiorella Ruatta

25 papers receiving 197 citations

Peers

Fiorella Ruatta
Yuki Takeyasu Japan
Carlos Pagan United States
Catherine Leyh Germany
Nanfeng Fan China
Yujia Chi China
Yakup Ergün Türkiye
Johan M. van Rooijen Netherlands
Yasunari Ubukata Japan
Akesu Sujie China
Yuki Takeyasu Japan
Fiorella Ruatta
Citations per year, relative to Fiorella Ruatta Fiorella Ruatta (= 1×) peers Yuki Takeyasu

Countries citing papers authored by Fiorella Ruatta

Since Specialization
Citations

This map shows the geographic impact of Fiorella Ruatta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiorella Ruatta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiorella Ruatta more than expected).

Fields of papers citing papers by Fiorella Ruatta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiorella Ruatta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiorella Ruatta. The network helps show where Fiorella Ruatta may publish in the future.

Co-authorship network of co-authors of Fiorella Ruatta

This figure shows the co-authorship network connecting the top 25 collaborators of Fiorella Ruatta. A scholar is included among the top collaborators of Fiorella Ruatta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiorella Ruatta. Fiorella Ruatta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrelli, Fausto, Antonio Ghidini, Carmen G. Rea, et al.. (2024). Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis. Current Problems in Cancer. 50. 101096–101096. 4 indexed citations
2.
Garrone, Ornella, Fiorella Ruatta, Giovanni Tomasello, et al.. (2024). Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response—the Neo-Runner study. ESMO Open. 9(8). 103665–103665. 4 indexed citations
3.
4.
Rea, Carmen G., Maria Chiara Parati, Karen Borgonovo, et al.. (2023). Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis. Anticancer Research. 43(10). 4303–4313. 6 indexed citations
5.
Garrone, Ornella, et al.. (2023). Moderate physical exercise and immune system modulation in patients with breast cancer treated with neoadjuvant chemotherapy.. Journal of Clinical Oncology. 41(16_suppl). 605–605. 1 indexed citations
6.
Astigiano, Simonetta, Stefania Martini, Fiorella Ruatta, et al.. (2022). Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules. Anticancer Research. 42(6). 2859–2867. 4 indexed citations
7.
Michelotti, Andrea, Elena Geuna, Fiorella Ruatta, et al.. (2022). Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression. Vaccines. 10(1). 78–78. 18 indexed citations
8.
Merlano, Marco, Nerina Denaro, Danilo Galizia, et al.. (2022). How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. Biomedicines. 10(8). 1822–1822. 25 indexed citations
9.
Garrone, Ornella, Fiorella Ruatta, Nerina Denaro, et al.. (2021). 157P Moderate physical activity (MPA) modulates immune system in breast cancer (BC) patients during preoperative chemotherapy: The NEO-RUNNER study. Annals of Oncology. 32. S429–S429. 1 indexed citations
10.
Garrone, Ornella, Nerina Denaro, Fiorella Ruatta, et al.. (2020). Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy. Tumori Journal. 106(5). 427–431. 1 indexed citations
11.
Ruatta, Fiorella, Lisa Derosa, Bernard Escudier, et al.. (2018). Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre. European Journal of Cancer. 107. 79–85. 59 indexed citations
12.
Ruatta, Fiorella, Lisa Derosa, Laurence Albigès, et al.. (2017). Prognosis of renal cell carcinoma with bone metastases: Experience in 300 consecutive patients.. Journal of Clinical Oncology. 35(6_suppl). 463–463. 3 indexed citations
13.
14.
Derosa, Lisa, Gwénaël Le Teuff, Brice Chanez, et al.. (2016). Brain and pancreatic metastases: A clinico-pathological comparison of various facets of tumor heterogeneity in renal cell carcinoma - The BRAVE project. Annals of Oncology. 27. vi287–vi287. 1 indexed citations
15.
Ponzone, Riccardo, Fiorella Ruatta, Marco Gatti, et al.. (2016). Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer. Cancer Treatment Reviews. 48. 1–7. 6 indexed citations
16.
Facchini, Gaetano, Orazio Caffo, Cinzia Ortega, et al.. (2016). Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival. Frontiers in Pharmacology. 7. 123–123. 32 indexed citations
17.
Cavaliere, Carla, Orazio Caffo, Cinzia Ortega, et al.. (2016). Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor to predict overall survival.. Journal of Clinical Oncology. 34(2_suppl). 219–219. 1 indexed citations
18.
Ruatta, Fiorella, Angela Gernone, Caterina Aversa, et al.. (2016). Prospective evaluation of the cardiovascular safety profile of abiraterone acetate (AA) in mCRPC patients (pts).. Journal of Clinical Oncology. 34(15_suppl). e16534–e16534. 2 indexed citations
19.
Veccia, Antonello, Orazio Caffo, Salvatore Luca Burgio, et al.. (2015). Impact of new agents (NAs) on post-docetaxel (DOC) survival of octogenarians with metastatic castration resistant prostate cancer (mCRPC) patients (pts): Results of an Italian multicenter retrospective study (DELPHI study).. Journal of Clinical Oncology. 33(15_suppl). e16017–e16017. 1 indexed citations
20.
Isaia, Giancarlo, Vittoria Tibaldi, Marco Ladetto, et al.. (2010). Home management of hematological patients requiring hospital admission. Archives of Gerontology and Geriatrics. 51(3). 309–311. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Takeyasu Breakdown of academic impact, for papers by Carlos Pagan Breakdown of academic impact, for papers by Catherine Leyh Breakdown of academic impact, for papers by Nanfeng Fan Breakdown of academic impact, for papers by Yujia Chi Breakdown of academic impact, for papers by Yakup Ergün Breakdown of academic impact, for papers by Johan M. van Rooijen Breakdown of academic impact, for papers by Yasunari Ubukata Breakdown of academic impact, for papers by Akesu Sujie
Rankless by CCL
2026